BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8186637)

  • 1. Effects of ozonation on mutagenic activity of nitrosamines.
    Fouillet B; Odoul M; Chambon P; Chambon R; Castegnaro M
    Bull Environ Contam Toxicol; 1994 May; 52(5):681-6. PubMed ID: 8186637
    [No Abstract]   [Full Text] [Related]  

  • 2. Transformation of Contaminant Candidate List (CCL3) compounds during ozonation and advanced oxidation processes in drinking water: Assessment of biological effects.
    Mestankova H; Parker AM; Bramaz N; Canonica S; Schirmer K; von Gunten U; Linden KG
    Water Res; 2016 Apr; 93():110-120. PubMed ID: 26900972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of orbitrap-MS/MS and QSAR analyses to estimate mutagenic transformation products of iopamidol generated during ozonation and chlorination.
    Matsushita T; Hashizuka M; Kuriyama T; Matsui Y; Shirasaki N
    Chemosphere; 2016 Apr; 148():233-40. PubMed ID: 26807944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenic activities of chiral epoxides, halides, and N-nitrosoamines.
    Yaguchi Y; Shiozawa T; Matsushita H; Terao Y
    Biol Pharm Bull; 1993 Sep; 16(9):942-4. PubMed ID: 8268866
    [No Abstract]   [Full Text] [Related]  

  • 5. Bacterial mutagenicity of some tobacco aromatic nitrogen bases and their mixtures.
    Yim SH; Hee SS
    Mutat Res; 2001 May; 492(1-2):13-27. PubMed ID: 11377240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ozonation on the mutagenicity of carcinogens in aqueous solution.
    Burleson GR; Chambers TM
    Environ Mutagen; 1982; 4(4):469-76. PubMed ID: 7117216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are all nitrosamines concerning? A review of mutagenicity and carcinogenicity data.
    Thresher A; Foster R; Ponting DJ; Stalford SA; Tennant RE; Thomas R
    Regul Toxicol Pharmacol; 2020 Oct; 116():104749. PubMed ID: 32777431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The superiority of hamster liver microsomal fraction for activating nitrosamines to mutagens in Salmonella typhimurium.
    Lijinsky W; Andrews AW
    Mutat Res; 1983 Oct; 111(2):135-44. PubMed ID: 6355832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between the carcinogenicity and mutagenicity of nitrosamines in a hepatocyte-mediated mutagenicity assay.
    Jones CA; Marlino PJ; Lijinsky W; Huberman E
    Carcinogenesis; 1981; 2(10):1075-7. PubMed ID: 7296760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micronucleus formation induced in rat liver and esophagus by nitrosamines.
    Mehta R; Silinskas KC; Zucker PF; Ronen A; Heddle JA; Archer MC
    Cancer Lett; 1987 Jun; 35(3):313-20. PubMed ID: 3594426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of mutagenicity during degradation of N-nitrosamines by advanced oxidation processes.
    Mestankova H; Schirmer K; Canonica S; von Gunten U
    Water Res; 2014 Dec; 66():399-410. PubMed ID: 25240607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High mutagenic activity of N-nitrosobis(2-oxopropyl)amine and N-nitrosobis(2-hydroxypropyl)amine in the host-mediated assay in hamsters: evidence for premutagenic methyl and hydroxylpropyl adducts.
    Guttenplan JB; Kokkinakis D
    Carcinogenesis; 1993 Aug; 14(8):1621-5. PubMed ID: 8353845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetic toxicology of N-nitrosodiphenylamine.
    McGregor D
    Mutat Res; 1994 Jun; 317(3):195-211. PubMed ID: 7515154
    [No Abstract]   [Full Text] [Related]  

  • 14. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds.
    Hakura A; Shimada H; Nakajima M; Sui H; Kitamoto S; Suzuki S; Satoh T
    Mutagenesis; 2005 May; 20(3):217-28. PubMed ID: 15843387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenic impurities in pharmaceuticals: A critical assessment of the cohort of concern with a focus on N-nitrosamines.
    Snodin DJ
    Regul Toxicol Pharmacol; 2023 Jun; 141():105403. PubMed ID: 37116739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of chemical structure on the extent and sites of carcinogenesis for 522 rodent carcinogens and 55 different human carcinogen exposures.
    Ashby J; Paton D
    Mutat Res; 1993 Mar; 286(1):3-74. PubMed ID: 7678908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of monoclonal antibodies to cytochrome P450s to indicate the critical dealkylation and the P450s involved in methyl-n-amylnitrosamine mutagenicity in the presence of induced rat liver microsomes.
    Mirvish SS; Huang Q; Williamson J; Chen SC; Gelboin HV
    Mutat Res; 1995 Sep; 331(1):161-70. PubMed ID: 7666863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeine-derived N-nitroso compounds. III: Mutagenicity in S. typhimurium and in vitro induction of DNA single-strand breaks in rat hepatocytes by mononitrosocaffeidine and dinitrosocaffeidine.
    Erdinger L; Schmezer P; Razdan R; Kumar R; Spiegelhalder B; Preussmann R; Siddiqi M
    Mutat Res; 1993 Aug; 292(1):41-9. PubMed ID: 7688096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of mutagenic transformation products generated during oxidation of 3-methyl-4-nitrophenol solutions by orbitrap tandem mass spectrometry and quantitative structure-activity relationship analyses.
    Matsushita T; Honda S; Kuriyama T; Fujita Y; Kondo T; Matsui Y; Shirasaki N; Takanashi H; Kameya T
    Water Res; 2018 Feb; 129():347-356. PubMed ID: 29169108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro toxicity of nitrosamines and nitramines associated with amine-based carbon capture and storage.
    Wagner ED; Osiol J; Mitch WA; Plewa MJ
    Environ Sci Technol; 2014 Jul; 48(14):8203-11. PubMed ID: 24940705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.